Arcadia Wealth Management (New Hampshire)’s CVS Health CVS Stock Holding History

Arcadia Wealth Management (New Hampshire)’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$254K	Buy	+2,451	New	+$219K	0.08%	65

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Arcadia Wealth Management (New Hampshire)'s CVS Position: Q2 2026 in Review

Arcadia Wealth Management (New Hampshire) opened a new position in CVS Health (CVS) in Q2 2026: 2,451 shares worth $254K. The stake represents 0.08% of the portfolio and ranks #65 among its holdings.

2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Arcadia Wealth Management (New Hampshire) held 2,451 shares of CVS Health worth $254K as of Q2 2026.
CVS Health was a new Arcadia Wealth Management (New Hampshire) position in Q2 2026.
CVS Health made up 0.08% of Arcadia Wealth Management (New Hampshire)'s portfolio in Q2 2026, its #65 holding.
2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Arcadia Wealth Management (New Hampshire)'s 13F filing for Q2 2026, filed 20 Jul 2026.